2018-2019 AdooQ 最新目录册 点击此处下载
微信关注
申请试用装

Microbiology | 微生物学



产品 1 到 50 共 185个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置升序顺序
Catalog No. Product Name Application Product Information
A10908 SALE

Tenofovir (Viread)

HIV reverse transcriptase 抑制剂
Tenofovir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood.
A11216 SALE

Entecavir

Reverse transcriptase 抑制剂
Entecavir is a nucleoside analog (more specifically, a guanosine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection.
A10909 SALE

Tenofovir Disoproxil Fumarate

nucleotide reverse transcriptase 抑制剂
Tenofovir Disoproxil Fumarate is employed as an anti-HIV agend and a reverse transcriptase inhibitor.
A11120 SALE

Abacavir sulfate

Transcriptase 抑制剂
Abacavir sulfate is a nucleoside analog reverse transcriptase inhibitor (NRTI); guanosine analog used to treat HIV and AIDS.
A11115 SALE

Abacavir

Transcriptase 抑制剂
Abacavir is a nucleoside analog reverse transcriptase inhibitor (NRTI); guanosine analog used to treat HIV and AIDS.
A10039 SALE

Adefovir dipivoxil

-
Adefovir dipivoxil is an orally-administered nucleotide analog reverse transcriptase inhibitor (ntRTI). It is used for treatment of hepatitis B and herpes simplex virus infection.
A11542 SALE

Rilpivirine (R 278474, TMC 278)

NNRT 抑制剂
Rilpivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
A10349 SALE

Emtricitabine

NRT 抑制剂
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection.
A10306

Didanosine

Reverse transcriptase 抑制剂
Didanosine is a reverse transcriptase inhibitor, effective against HIV and used in combination with other antiretroviral drug therapy as part of highly active antiretroviral therapy (HAART).
A12443

MK-1439

NNRT 抑制剂
MK-1439 is a non-nucleoside reverse transcriptase inhibitor
A10639 SALE

Nevirapine (Viramune)

-
Nevirapine (Viramune) is a potent (IC50=84nM) and selective non-nucleoside inhibitor of HIV-1 reverse transcriptase.
A12587 SALE

Dapivirine

HIV reverse transcriptase 抑制剂
Dapivirine is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI)
A12667

Lersivirine (UK-453061)

NNRT 抑制剂
Lersivirine (UK-453,061) is a next-generation nonnucleoside reverse transcriptase inhibitor, active against wild-type HIV-1 and several nonnucleoside reverse transcriptase inhibitor-resistant strains.
A10512 SALE

Lamivudine

-
Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor (nRTI).
A14435

Elvucitabine

NRT 抑制剂
Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).
A15428

Zidovudine

NRTI 抑制剂
Zidovudine is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the treatment of HIV/AIDS infection. Azidothymidine decreases CRISPR-mediated homology directed repair (HDR) efficiency.
A15772

GS-7340

NRT 抑制剂
GS-7340 is a prodrug of tenofovir (TFV) that more efficiently delivers TFV into lymphoid cells and tissues than TFV disoproxil fumarate.
A10775 SALE

Raltegravir (MK-0518)

HIV-1 integrase 抑制剂
Raltegravir (MK-0518) targets integrase, an HIV enzyme that integrates the viral genetic material into human chromosomes, a critical step in the pathogenesis of HIV.
A11068 SALE

S/GSK1349572 (Dolutegravir)

HIV integrase 抑制剂
S/GSK1349572 is a potent next generation HIV integrase inhibitor and demonstrates a superior resistance profile substantiated with 60 integrase mutant molecular clones.
A11135

MK-2048

HIV integrase 抑制剂
MK-2048 is a second generation integrase inhibitor, intended to be used against HIV infection.
A10156

BMS-707035

HIV-1 integrase 抑制剂

BMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.

A10347 SALE

Elvitegravir (GS-9137)

HIV integrase 抑制剂
Elvitegravir (GS-9137) is a potent inhibitor of the strand-transfer step of integration mediated by human immunodeficiency virus type 1 (HIV-1) integrase.
A13984

GSK1265744 (GSK744) Sodium salt

HIV Integrase 抑制剂
GSK1265744 (GSK744) is a potential inhibitor of HIV integrase with IC50 value of 3 nM
A16014

GSK744 (S/GSK1265744)

HIV integrase 抑制剂
GSK744 is a potent HIV integrase inhibitor as an oral lead-in tablet and long-acting injectable for the treatment and prevention of HIV infection.
A16018

BI 224436

HIV integrase 抑制剂
BI 224436 is a novel HIV-1 non-catalytic-site integrase inhibitor; has antiviral EC50s of <15 nM against different HIV-1 laboratory strains and cellular cytotoxicity of >90 μM.
A16162

Dolutegravir Sodium

HIV integrase 抑制剂
Dolutegravir sodium is a HIV integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
A10159 SALE

BMS-790052 (Daclatasvir)

HCV NS5A 抑制剂
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
A10284 SALE

Danoprevir (RG7227)

HCV NS3/4A protease 抑制剂
Danoprevir is a potent inhibitor of the HCV NS3/4A serine protease.
A10980

VX-222

HCV Protease 抑制剂
VX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
A10902 SALE

Telaprevir (VX-950)

HCV NS3-4A protease 抑制剂
Telaprevir (VX-950) is known as protease inhibitors that inhibits the hepatitis C virus NS3.4A serine protease.
A11294

Anguizole

HCV replication 抑制剂
Anguizole is a small molecule inhibits HCV replication and alters NS4B's subcellular distribution.
A11295 SALE

Asunaprevir (BMS-650032)

NS3 protease 抑制剂
Asunaprevir is an inhibitor of the viral enzyme serine protease NS3.
A11332 SALE

Boceprevir (SCH-503034)

HCV Protease 抑制剂
Boceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
A11335

Balapiravir (R1626)

Polymerase 抑制剂
Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
A11336

BMS-790052 2HCl

NS5A 抑制剂
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
A11343 SALE

Ciluprevir (BILN 2061)

HCV NS3 protease 抑制剂
Ciluprevir is a specific and potent peptidomimetic inhibitor of the HCV NS3 protease.
A11519 SALE

PSI-6130

HCV Nucleoside 抑制剂
PSI-6130(R 1656) is a Hepatitis C Virus Nucleoside Inhibitor.
A11583

Tegobuvir (GS-9190)

NS5B polymerase 抑制剂
Tegobuvir (GS-9190 is a non-nucleoside NS5B polymerase inhibitor.
A12374

VCH-916

HCV NS5B polymerase 抑制剂
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
A13105

Setrobuvir (ANA-598)

HCV Polymerase 抑制剂
Setrobuvir (ANA-598) is a direct-acting antiviral or DAA, is a non-nucleoside inhibitor of the HCV RNA polymerase
A13118

Celgosivir

alpha-glucosidase I 抑制剂
Celgosivir is an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.
A13155 SALE

Ledipasvir (GS 5885)

NS5A 抑制剂
Ledipasvir is an inhibitor of the hepatitis C virus HCV NS5A protein
A11529 SALE

PSI-7977

HCV Nucleotide 抑制剂
PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).
A11530 SALE

PSI-6206

HCV RNA polymerase 抑制剂
PSI-6206 is the deaminated derivative of PSI-6130, which is a potent inhibitor of hepatitis C virus (HCV) replication in the subgenomic HCV reolicon system.
A14106

Faldaprevir

HCV Protease 抑制剂
Faldaprevir is a hepatitis C virus protease inhibitor.
A13965

MK 8742 (elbasvir)

HCV NS5A 抑制剂
MK 8742, also known as Elbasvir, is a HCV NS5A inhibitor, which is an all-oral, interferon-free regimen for the treatment of HCV infection.
A14046

GS-9451

HCV NS3/4A protease 抑制剂
GS-9451, a novel hepatitis C virus (HCV) nonstructural 3/4a (NS3/4a) protease inhibitor, is highly active in patients infected with HCV genotype 1 (GT 1).
A15166

MK-5172 hydrate

HCV 抑制剂
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15167

MK-5172 potassium salt

HCV 抑制剂
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15168

MK-5172 sodium salt

HCV 抑制剂
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.

产品 1 到 50 共 185个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置升序顺序